Mercaptamine hydrochloride for corneal cystine deposits in people aged older than 2 years

Closed 1 Sep 2019

Opened 2 Aug 2019

Results Updated 13 Mar 2020

Last year NHS England launched a 30 day consultation on the use of mercaptamine hydrochloride for corneal cystine deposits. The outcome of this consultation was to agree that this treatment should be considered further for routine commissioning, however when it was considered within the prioritisation process at the meeting of our Clinical Priorities Advisory Group in November 2019, it was not one of the treatments that we were able to fund at that time.

We are planning to consider again the use of mercaptamine hydrochloride for corneal cystine deposits at the next CPAG meeting in May 2020.

We have recently updated our CPAG process to include a full Equalities and Health Inequalities Impact Assessment (EHIA) as one of the papers that we share as part of the policy consultation, and as that paper was not included in the original consultation for this treatment, we are now sharing the EHIA for this policy proposition. We welcome any further feedback from stakeholders to ensure that we have fully captured all the health and health inequality issues for this treatment before it is considered as one of the final CPAG papers.

If you have any comments on the EHIA, please contact england.npoc-internalmedicine@nhs.net by 12 April 2020.

Files:

Overview

NHS England has launched a 30 day consultation on the use of mercaptamine hydrochloride for corneal cystine deposits

Related documents

Audiences

  • GPs
  • Nurses
  • Health visitors
  • Clinicians
  • Managers
  • Commissioners
  • Directors of public health
  • Pharmacists
  • Doctors
  • Midwives
  • Health care assistants
  • Healthcare scientists
  • Paramedics
  • Chiropodists/podiatrists
  • Dietitians
  • Occupation therapists
  • Orthotists
  • Orthopists
  • Prosthesists
  • Physiotherapists
  • Diagnostic radiographers
  • Therapeutic radiographers
  • Speech and language therapists
  • Childcare providers
  • Allied health professionals
  • Care-givers
  • Ophthalmic practitioners
  • Responsible officers
  • Clinical psychologists
  • Paediatric neuropsychologists
  • GP Practices
  • Clinical Nurse Specialist
  • Practice managers
  • Receptionists
  • Dental surgeons
  • Neonatal and maternity staff
  • Foundation trusts
  • Mental health trusts
  • Community healthcare trusts
  • Tribunal service
  • Clinical commissioning groups (CCGs)
  • Commissioning support units (CSUs)
  • Strategic clinical networks (SCNs)
  • GP Practices
  • Primary care
  • Care Quality Commission
  • Health Education England
  • Health Protection Agency
  • Local Government Association
  • Monitor
  • National Institute for Health and Care Excellence
  • Health and Wellbeing boards
  • Healthwatch (national and local)
  • Health and Social Care Information Centre
  • NHS Trust Development Authority
  • NHS England Partnership Organisations
  • National directors
  • Regional directors
  • Area Team directors
  • All NHS England Staff
  • All P&I staff
  • Policy leads
  • Voluntary groups
  • Community groups
  • Charities
  • Advocacy or support organisations
  • DH third sector strategic partners
  • Regulatory bodies
  • Academic/professional institutions
  • Employer representatives
  • Employee representatives
  • Trade unions
  • Deaneries
  • Higher education institutions
  • Royal Colleges
  • Service providers
  • All interested stakeholders
  • Pharmaceutical Industry
  • Local authorities
  • Social care providers
  • Patients
  • Carers
  • Service users
  • Retailers
  • Suppliers
  • Information providers
  • Information professionals
  • Informatics professionals

Interests

  • Specialised commissioning